National health spending in 2004: recent slowdown led by prescription drug spending.
about
Economic costs of diabetes in the U.S. in 2012Economic burden of occupational injury and illness in the United StatesPrescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey.Health spending by state of residence, 1991-2009.Improved estimates of capital formation in the National Health Expenditure AccountsFuture directions for the national health expenditure accounts: conference overview.Reconciling medical expenditure estimates from the MEPS and NHEA, 2002Impact of resource-based practice expenses on the Medicare physician volume.Date stamping: will it withstand the test of time?Persistent medication affordability problems among disabled Medicare beneficiaries after Part D, 2006-2011Prior authorization of newer insomnia medications in managed care: is it cost saving?The financial burden from prescription drugs has declined recently for the nonelderly, although it is still high for many.Impact of Medicaid prior authorization requirement for COX-2 inhibitor drugs in Nebraska.Should pharmacogenomic studies be required for new drug approval?Ownership conversions and nursing home performance.What if the federal government negotiated pharmaceutical prices for seniors? An estimate of national savings.Changes over time in high out-of-pocket health care burden in U.S. adults with diabetes, 2001-2011Path toward economic resilience for family caregivers: mitigating household deprivation and the health care talent shortage at the same timeCost-related medication nonadherence and spending on basic needs following implementation of Medicare Part D.Ownership status and home health care performance.Publication patterns of cancer cost-effectiveness studies presented at major conferences.Cost sharing and the initiation of drug therapy for the chronically ill.Update on the changing numbers and distribution of periodontists.The cost-effectiveness of direct-to-consumer advertising for prescription drugs.Healthcare cost and predictive factors: high- and low-utilization model development.Differences in prescription drug use in HMO and self-insured health plans.US health spending reaches a sixth of gross domestic product.Time to finance health insurance differently.Which physicians are affected most by Medicaid preferred drug lists for statins and antihypertensives?Reducing the Cost of Critical Care: New Challenges, New SolutionsThe Differential Performance Effects of Healthcare Information Technology Adoption
P2860
Q22241287-4F9DF368-4B8B-4F2D-B4A9-B74B836FEEB4Q23914006-C57B7B9D-776A-4F6A-A288-12DBEB5A52FCQ33515398-0F4C0BDE-5E07-49FB-96E5-59D09DBDB095Q33567857-3393E785-C8D9-4458-BC90-DDF039AAEED1Q34328582-E77B0138-4B1D-42A2-B6A8-840305FD47ECQ34328616-B2763F62-A36F-4EE9-8EE5-0D309D6D9AD0Q34328626-C63F0670-1E6B-4C58-A6B5-0EFCB2D81434Q34328892-670A44E3-67B3-4010-9242-AFACC2699084Q35633870-3EB64159-2CE2-449F-97CF-EFC6992A5C68Q35963348-AE98927B-971C-4298-99CA-40F55195B9AFQ35995325-AB35D696-7730-4B12-87C8-F29A7D8240F2Q36070889-4F98BF4A-802B-4804-B8EA-FBBCD772646FQ36570328-6A08B671-AD25-4818-AC8E-691ACB8DDFC8Q36752667-D4CA5429-6C18-4B73-8227-B770AA9E1DB0Q36839657-B8D3FB30-F9B8-4793-80E5-319784E1F80CQ36841041-97597F27-6E56-46F2-8D2B-5BA7AB1A16D3Q37021408-E000568B-5758-4839-9040-3010792289BDQ37167290-56D97F15-E4B8-44E4-A400-50CF2A10E478Q37194705-16AE8FE7-2AAF-44BB-B358-F187C8296F13Q37346824-BC7558CB-03FE-41AA-A342-5E96AA214A1EQ37364578-9CA9596E-C5A4-4E28-8048-500B0338531BQ37419499-2A5914E9-7C67-426C-95B1-EBFA83398BC3Q37465298-78F63FBE-C2E4-4C7B-8DB4-583939BECE4DQ37474156-D883F91D-B1CC-4322-8DD5-3F343389D0F2Q39940585-791420A7-66AD-485A-94BE-BE74FFE39860Q42608495-553958E8-6091-41E6-A5A4-8033DDD223B3Q46058477-55416BB4-2820-4A21-8F20-198B515ED9CFQ50092398-9B5B0E63-D3B7-46C8-8C5C-CE699E531FE0Q50179293-9C1CC3AA-A0B8-4AF3-AD2D-FA83B9CB32DDQ56929038-2BA7E652-6C2C-4061-924C-5F7D93A7B0B4Q58517850-0CF811C9-C3A2-4FD1-B66E-139E1FB33127
P2860
National health spending in 2004: recent slowdown led by prescription drug spending.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh
2006年學術文章
@zh-hant
name
National health spending in 2004: recent slowdown led by prescription drug spending.
@en
National health spending in 2004: recent slowdown led by prescription drug spending.
@nl
type
label
National health spending in 2004: recent slowdown led by prescription drug spending.
@en
National health spending in 2004: recent slowdown led by prescription drug spending.
@nl
prefLabel
National health spending in 2004: recent slowdown led by prescription drug spending.
@en
National health spending in 2004: recent slowdown led by prescription drug spending.
@nl
P2093
P356
P1433
P1476
National health spending in 2004: recent slowdown led by prescription drug spending.
@en
P2093
Aaron Catlin
Cathy Cowan
Cynthia Smith
Stephen Heffler
P304
P356
10.1377/HLTHAFF.25.1.186
P407
P577
2006-01-01T00:00:00Z